Oruka Therapeutics (ORKA) Accumulated Depreciation & Amortization (2011 - 2024)
Oruka Therapeutics (ORKA) recorded quarterly Accumulated Depreciation & Amortization of $218000.0 in Q2 2024, up 1.4% quarter-over-quarter from $215000.0 in Q1 2024, and up 2.83% on a YoY basis from $212000.0 in Q3 2023.
Oruka Therapeutics (ORKA) Accumulated Depreciation & Amortization (2011 - 2024) Analysis & Trends
Oruka Therapeutics' Accumulated Depreciation & Amortization history runs 14 years deep, the most recent figure standing at $218000.0 for Q2 2024.
- In Q2 2024, Accumulated Depreciation & Amortization rose 2.83% year-over-year to $218000.0; the TTM figure through Jun 2024 stood at $218000.0 (up 2.83% YoY), while the FY2023 annual figure was $212000.0, up 3.92% from the prior year.
- Accumulated Depreciation & Amortization was $218000.0 for Q2 2024 at Oruka Therapeutics, up from $215000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $370000.0 in Q1 2020 to a low of $195000.0 in Q4 2021.
- Historically, Accumulated Depreciation & Amortization has averaged $232722.2 across 5 years, with a median of $213500.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Accumulated Depreciation & Amortization slumped 38.37% in 2021, then climbed 7.46% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $250000.0 in 2020, then retreated by 22.0% to $195000.0 in 2021, then increased by 4.62% to $204000.0 in 2022, then rose by 3.92% to $212000.0 in 2023, then increased by 2.83% to $218000.0 in 2024.
- The last three Accumulated Depreciation & Amortization figures came in at $218000.0 (Q2 2024), $215000.0 (Q1 2024), and $212000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oruka Therapeutics | 3.86 Bn | 3.47 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 215,000.00 |
| Mar 31, 2024 | 215,000.00 |
| Dec 31, 2023 | 212,000.00 |
| Dec 31, 2023 | 212,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 208,000.00 |
| Mar 31, 2023 | 208,000.00 |
| Dec 31, 2022 | 204,000.00 |
| Dec 31, 2022 | 204,000.00 |
| Sep 30, 2022 | 201,000.00 |
| Sep 30, 2022 | 201,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Mar 31, 2022 | 198,000.00 |